查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1258198

2022-2029 年全球血浆蛋白治疗市场规模研究与预测按产品类型,应用和地区分析

Global Plasma Protein Therapeutics Market Size study & Forecast, by Product Type, by Application and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3个工作天内

价格

2021 年全球血浆蛋白治疗市场价值约为 274,5 亿美元，预计在 2022-2029 年预测期内将以超过 7% 的健康增长率增长。

血浆蛋白製品是由血浆组成的生物药品。 血浆是一种生物材料，根据其製造和加工方式的不同，其化学成分也不同。 血液主要由血浆组成，含有水,盐,蛋白质,抗体和□。 由于免疫缺陷病发病率增加和老年人口快速增长等因素，血浆蛋白市场正在扩大。 由于免疫缺陷疾病增加和人口老龄化等因素，血浆蛋白市场正在扩大。

血浆蛋白用于治疗各种慢性,危及生命和遗传性疾病。 它的受欢迎程度在过去几年中逐渐增加。 据 Statista 称，到 2020 年，全球血浆需求预计将增长 5000 万升。 此外，到 2020 年，全球将消耗 1018,8 公吨白蛋白，预计到 2022 年将达到约 1125,5 公吨。 它是世界上用于癌症诊断和治疗的血浆产生的蛋白质，以及莫布斯·威尔逊的治疗方法。 主要用于癌症的诊断和治疗。 推动空间增长的另一个关键因素是不断增长的老龄化人口。 到 2022 年，摩纳哥 65 岁及以上人口占总人口的比例将最高。 摩纳哥是世界上人口老龄化速度最快的国家，其中 36% 的日本人超过 65 岁。 到 2022 年，德国将有 22% 的人口超过 65 岁。 世界上大约 25% 的人口年龄在 15 岁以下，10% 的人口年龄在 65 岁以上。 世界上最年轻的人口在非洲。 许多国家的预期寿命也很低，40% 的人口年龄在 15 岁以下，65 岁以上的人口不到 4%。 另一方面，在欧洲，65 岁及以上的人口多于 15 岁以下的人口。 2021年，百特国际宣布在全球推出PrisMax2。 它旨在简化连续肾臟替代疗法和器官支持血浆疗法的实施，并提供灵活性以满足重症监护病房的需求。 PrisMax 2 具有我们的 TrueVue 数字健康产品组合和 PrismaLung 血气交换器，可提供体外 decaprulation 治疗以支持急性呼吸功能障碍。 然而，血浆蛋白产品的高成本将阻碍整个 2022-2029 年预测期内的市场增长。

全球血浆蛋白产品市场研究考虑的主要区域是亚太地区,北美,欧洲,拉丁美洲和世界其他地区。 由于医疗保健支出增加，北美在收入方面占据主导地位。 根据 Statista 的数据，北美医疗保健行业预计 2023 年将达到 207,7 亿美元，2023 年至 2027 年的年增长率为 12,25%，预计 2027 年市场规模将达到 329,7 亿美元，预计将达到美元,

本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模，并预测未来几年的市场规模。 该报告旨在捕捉被调查国家行业的定性和定量方面的情况。

它还提供了关键方面的详细信息，例如决定市场未来增长的驱动因素和挑战。 此外，它还包含供利益相关者投资的潜在微观市场机会，以及对主要参与者的竞争格局和产品供应的深入分析。

内容

第 1 章执行摘要

  • 市场概况
  • 2019-2029 年各细分市场的全球市场估计和预测
    • 血浆蛋白市场，按地区划分，2019-2029 年
    • 血浆蛋白市场，按产品类型，2019-2029 年
    • 血浆蛋白市场，按应用，2019-2029
  • 主要趋势
  • 调查方法
  • 调查先决条件

第 2 章全球血浆蛋白市场定义和范围

  • 调查目的
  • 市场定义和范围
    • 调查范围
    • 工业发展
  • 本次调查涵盖的年份
  • 货币兑换率

第3章血浆蛋白产品的全球市场动态

  • 血浆蛋白製品市场影响分析(2019-2029)
    • 市场驱动力
      • 免疫缺陷病的发病率增加
      • 老年人口激增
    • 市场挑战
      • 血浆蛋白製剂的成本较高
    • 市场机会
      • 製药公司增加对研发项目的投资

第 4 章全球血浆蛋白市场行业分析

  • 波特 5 力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法 (2019-2029)
  • 害虫分析
    • 政治
    • 经济的
    • 社交
    • 技术
  • 主要投资机会
  • 关键成功策略
  • 业内人士的前景
  • 分析师的建议和结论

第 5 章风险评估：COVID-19 的影响

  • 评估 COVID-19 对行业的总体影响
  • COVID-19 之前和 COVID-19 之后的市场情景

第 6 章全球血浆蛋白市场：按产品类型分类

  • 市场概况
  • 全球血浆蛋白产品市场：按产品类型,性能 - 潜力分析
  • 2019-2029 年按产品类型分列的世界血浆蛋白产品市场估算和预测
  • 血浆蛋白产品市场细分分析
    • C1 酯□抑製剂
    • 白蛋白
    • 免疫球蛋白
    • 其他

第 7 章全球血浆蛋白市场：按应用

  • 市场概况
  • 世界血浆蛋白产品市场：按应用,性能 - 潜力分析
  • 2019-2029 年血浆蛋白产品的世界市场估计和预测(按应用)
  • 血浆蛋白产品市场细分分析
    • 遗传性血管性水肿
    • 血友病
    • Genpatsuseimen Ekifuzensho
    • 其他

第 8 章全球血浆蛋白市场：区域分析

  • 血浆蛋白市场，按地区划分的市场概况
  • 北美
    • 美国
      • 按产品类型估算和预测，2019 年至 2029 年
      • 按应用分类的估计和预测，2019-2029 年
    • 加拿大
  • 欧洲血浆蛋白市场概况
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 意大利
    • 其他欧洲
  • 亚太地区血浆蛋白市场概况
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 韩国
    • 其他亚太地区
  • 拉丁美洲血浆蛋白市场概况
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地区
  • 世界其他地区

第 9 章衝突信息

  • 顶级市场策略
  • 公司简介
    • 百特国际
      • 关键信息
      • 概览
      • 财务(仅当数据可用时)
      • 产品概览
      • 近期趋势
    • Biotest
    • CSL Behring
    • China Biologics
    • GRIFOLS SA
    • Kedrion
    • Octapharma USA Inc
    • Shire Plc
    • Takeda Pharmaceutical Company Ltd
    • ADMA Biologics Inc

第 10 章研究过程

  • 研究过程
    • 数据挖掘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 调查的特点
  • 调查先决条件

Global Plasma Protein Therapeutics Market is valued at approximately USD 27.45 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 7% over the forecast period 2022-2029. Plasma protein therapeutics is a biological medicine made up of plasma. It is a biological substance with a distinct chemical composition depending upon how it was produced and processed. The majority of blood is made up of plasma, contains water, salts, proteins, antibodies, and enzymes. The Plasma Protein Therapeutics market is expanding because of factors such as increasing incidence of immune deficiency disorder and surge in geriatric populations. Its prevalence has progressively increased during the last few years.

Plasma protein therapies are used in the treatment of various chronic, life-threatening, and genetic diseases. Its prevalence has progressively increased during the last few years. According to Statista, plasma demand around the world was expected to increase up to 50 million liters by 2020. Furthermore, in 2020, more than 1018.8 metric tons of albumin were consumed worldwide and projected to reach around 1125.5 metric tons by 2022. It is a global protein generated from blood plasma used for cancer diagnostics and therapies, and Morbus Wilson treatments. It is used mostly for cancer diagnostics and therapies. Another important component driving space is increasing geriatric populations. In 2022, Monaco was the country with the highest percentage of total population that was over the age of 65. Monaco has the oldest population in the world with 36 percent of Japanese over 65. Germany on the other hand has 22 percent of its population being over 65 in 2022. In addition Approximately 25% of the world's population is under 15, while 10% is over 65. The youngest population in the world is found in Africa. Indicating the low life expectancy in many nations, 40% of people on the continent are under the age of 15 and less than 4% are over 65. Contrarily, in Europe, a greater proportion of the population is over 65 than is under 15 years old. Furthermore, in 2021 Baxter International Inc. announced the global launch of PrisMax 2. It is designed to simplify delivery of continuous renal replacement therapy and organ support plasma therapies, while providing flexibility to meet the demands of the intensive care unit . The PrisMax 2 system features the company's TrueVue digital health portfolio, as well as the PrismaLung blood-gas exchanger that delivers extracorporeal carbon dioxide removal therapy to support acute respiratory dysfunction. However, the high cost of Plasma Protein Therapeutics stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Plasma Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, owing to the dominance of increase in healthcare expenditure. According to Statista, the Health Care segment of north America is projected to reach USD 20.77 billion in 2023 and expected to show an annual growth rate of 12.25% in between 2023 to 2027, resulting in a projected market volume of USD 32.97 billion by 2027.Furthermore, Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing research and development related to plasma protein therapies in the market space.

Major market players included in this report are:

  • Baxter International
  • Biotest
  • CSL Behring
  • China Biologics
  • GRIFOLS, S.A.
  • Kedrion
  • Octapharma USA, Inc
  • Shire Plc
  • Takeda Pharmaceutical Company Ltd
  • ADMA Biologics, Inc

Recent Developments in the Market:

  • In April 2020, Kedrion Biopharma collaborated with Kamada Ltd. For manufacturing, development, and distribution of a human plasma-derived Anti-SARS-CoV-2 (COVID-19) polyclonal immunoglobulin (IgG) product as a potential treatment for COVID-19 patients

Global Plasma Protein Therapeutics Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Product Type, Application, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Product Type:

  • C1 esterase Inhibitors
  • Albumins
  • Immunoglobulins
  • Others

By Application:

  • Hereditary Angioedema
  • Hemophilia
  • Primary Immunodeficiency Disorder
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Plasma Protein Therapeutics Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Plasma Protein Therapeutics Market, by Product Type, 2019-2029 (USD Billion)
    • 1.2.3. Plasma Protein Therapeutics Market, by Application, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Plasma Protein Therapeutics Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Plasma Protein Therapeutics Market Dynamics

  • 3.1. Plasma Protein Therapeutics Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing incidence of immune deficiency disorders
      • 3.1.1.2. Surge in geriatric populations
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Plasma Protein Therapeutics
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising investments in research and development programs by the pharmaceutical companies

Chapter 4. Global Plasma Protein Therapeutics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Plasma Protein Therapeutics Market, by Product Type

  • 6.1. Market Snapshot
  • 6.2. Global Plasma Protein Therapeutics Market by Product Type, Performance - Potential Analysis
  • 6.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Product Type 2019-2029 (USD Billion)
  • 6.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
    • 6.4.1. C1 esterase Inhibitors
    • 6.4.2. Albumins
    • 6.4.3. Immunoglobulins
    • 6.4.4. Others

Chapter 7. Global Plasma Protein Therapeutics Market, by Application

  • 7.1. Market Snapshot
  • 7.2. Global Plasma Protein Therapeutics Market by Application, Performance - Potential Analysis
  • 7.3. Global Plasma Protein Therapeutics Market Estimates & Forecasts by Application 2019-2029 (USD Billion)
  • 7.4. Plasma Protein Therapeutics Market, Sub Segment Analysis
    • 7.4.1. Hereditary Angioedema
    • 7.4.2. Haemophilia
    • 7.4.3. Primary Immunodeficiency Disorder
    • 7.4.4. Others

Chapter 8. Global Plasma Protein Therapeutics Market, Regional Analysis

  • 8.1. Plasma Protein Therapeutics Market, Regional Market Snapshot
  • 8.2. North America Plasma Protein Therapeutics Market
    • 8.2.1. U.S. Plasma Protein Therapeutics Market
      • 8.2.1.1. Product Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Application breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Plasma Protein Therapeutics Market
  • 8.3. Europe Plasma Protein Therapeutics Market Snapshot
    • 8.3.1. U.K. Plasma Protein Therapeutics Market
    • 8.3.2. Germany Plasma Protein Therapeutics Market
    • 8.3.3. France Plasma Protein Therapeutics Market
    • 8.3.4. Spain Plasma Protein Therapeutics Market
    • 8.3.5. Italy Plasma Protein Therapeutics Market
    • 8.3.6. Rest of Europe Plasma Protein Therapeutics Market
  • 8.4. Asia-Pacific Plasma Protein Therapeutics Market Snapshot
    • 8.4.1. China Plasma Protein Therapeutics Market
    • 8.4.2. India Plasma Protein Therapeutics Market
    • 8.4.3. Japan Plasma Protein Therapeutics Market
    • 8.4.4. Australia Plasma Protein Therapeutics Market
    • 8.4.5. South Korea Plasma Protein Therapeutics Market
    • 8.4.6. Rest of Asia Pacific Plasma Protein Therapeutics Market
  • 8.5. Latin America Plasma Protein Therapeutics Market Snapshot
    • 8.5.1. Brazil Plasma Protein Therapeutics Market
    • 8.5.2. Mexico Plasma Protein Therapeutics Market
    • 8.5.3. Rest of Latin America Plasma Protein Therapeutics Market
  • 8.6. Rest of The World Plasma Protein Therapeutics Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Baxter International
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Biotest
    • 9.2.3. CSL Behring
    • 9.2.4. China Biologics
    • 9.2.5. GRIFOLS, S.A.
    • 9.2.6. Kedrion
    • 9.2.7. Octapharma USA, Inc
    • 9.2.8. Shire Plc
    • 9.2.9. Takeda Pharmaceutical Company Ltd
    • 9.2.10. ADMA Biologics, Inc

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Plasma Protein Therapeutics Market, report scope
  • TABLE 2. Global Plasma Protein Therapeutics Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Plasma Protein Therapeutics Market estimates & forecasts by Product Type 2019-2029 (USD Billion)
  • TABLE 4. Global Plasma Protein Therapeutics Market estimates & forecasts by Application 2019-2029 (USD Billion)
  • TABLE 5. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Plasma Protein Therapeutics Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Plasma Protein Therapeutics Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Plasma Protein Therapeutics Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Plasma Protein Therapeutics Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Plasma Protein Therapeutics Market
  • TABLE 70. List of primary sources, used in the study of global Plasma Protein Therapeutics Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Plasma Protein Therapeutics Market, research methodology
  • FIG 2. Global Plasma Protein Therapeutics Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Plasma Protein Therapeutics Market, key trends 2021
  • FIG 5. Global Plasma Protein Therapeutics Market, growth prospects 2022-2029
  • FIG 6. Global Plasma Protein Therapeutics Market, porters 5 force model
  • FIG 7. Global Plasma Protein Therapeutics Market, pest analysis
  • FIG 8. Global Plasma Protein Therapeutics Market, value chain analysis
  • FIG 9. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Plasma Protein Therapeutics Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Plasma Protein Therapeutics Market, regional snapshot 2019 & 2029
  • FIG 15. North America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia Pacific Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Plasma Protein Therapeutics Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Plasma Protein Therapeutics Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable